Actionable news
All posts from Actionable news
Actionable news in MYGN: Myriad Genetics, Inc.,

Myriad Genetics (MYGN) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas LLC identified Myriad Genetics ( MYGN) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Myriad Genetics as such a stock due to the following factors:

  • MYGN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $48.4 million.
  • MYGN has traded 124,744 shares today.
  • MYGN is down 3% today.
  • MYGN was up 9.1% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in MYGN with the Ticky from Trade-Ideas. See the FREE profile for MYGN NOW at Trade-Ideas More details on MYGN: Myriad Genetics, Inc., a personalized medicine company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide. MYGN has a PE ratio of 39. Currently there are 5 analysts that rate Myriad Genetics a buy, 2 analysts rate it a sell, and 6 rate it a hold. The average volume for Myriad Genetics has been 961,600 shares per day over the past 30...